Development of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones as orally active human chymase inhibitors.

Bioorg Med Chem Lett

Biomedical Research Laboratories, Daiichi Asubio Pharma Co., Ltd, Mishima-gun, Osaka 618-8513, Japan.

Published: June 2007

A novel series of 6-benzyl substituted 4-aminocarbonyl-1,4-diazepane-2,5-diones was designed, synthesized, and evaluated as human chymase inhibitors. From this series, we identified several compounds which were effective, via oral administration, in a mouse model of chronic dermatitis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2007.03.085DOI Listing

Publication Analysis

Top Keywords

6-benzyl substituted
8
substituted 4-aminocarbonyl-14-diazepane-25-diones
8
human chymase
8
chymase inhibitors
8
development 6-benzyl
4
4-aminocarbonyl-14-diazepane-25-diones orally
4
orally active
4
active human
4
inhibitors novel
4
novel series
4

Similar Publications

Here, we present the light-driven reactions of [Re(η-CH)(η-CH)] () with nitriles, phosphines, and isocyanides, which are added to via a ring slippage of the tropylium cation from η to η, forming [Re(η-CH)(η-CH)(L)] (L= acetonitrile ; 2-phenylacetonitrile ; 1,3,5-triaza-5-phosphoadamantane (PTA) ; -butyl isocyanide ; benzyl isocyanide ) and [Re(η-CH)(η-CH)(L)] with L = (ethane-1,2-diyl)bis(diphenylphosphane) (dppe) . To compare the reactivities of rhenium and technetium, we also investigated the synthesis of [Tc(η-CH)], its substitution of naphthalene with cyclohepta-1,3,5-triene to obtain [Tc(η-CH)(η-CH)], and its reactivity (or lack thereof) with light.

View Article and Find Full Text PDF

The synthesis of bromo-substituted indeno[1,2-]pyridin-2-ones and 3-iodo-5-benzyl-substituted 2-pyridones, starting from easily available 6-benzyl-3,6-dihydropyridin-2(1)-ones, triggered by NBS and NIS, respectively, is described. In both syntheses, a transfer of a benzyl group from the C6 to C5 lactam position occurred, indicating a novel aza-semipinacol-type rearrangement. Identification of intermediate compounds in both transformations supported the proposed reaction mechanisms.

View Article and Find Full Text PDF

Background: Hexahydro-2H-pyrano[3,2-c]quinolines are known to have antibacterial, antifungal, and antitumor properties. Great efforts have been made to develop new synthetic methods that lead to the synthesis of valuable libraries. Extensive methodologies, low yields, excessive amounts of catalyst and expensive reactants are some of the limitations of current methodologies.

View Article and Find Full Text PDF

Some novel derivatives of 2-alkyl 6-substituted pyridazin-3(2H)-ones were synthesized by condensation of 3,6-dichloropyridazine with the sodium salt of benzyl cyanide, followed by hydrolysis and coupling with alkyl halides. The synthesized compounds were screened as cyclooxygenase (COX)-1/COX-2 inhibitors and as analgesic and anti-inflammatory agents. Among the synthesized compounds, 6-benzyl-2-methylpyridazin-3(2H)-one (4a), 6-benzoyl-2-propylpyridazin-3(2H)-one (8b), and 6-(hydroxy(phenyl)methyl)-2-methylpyridazin-3(2H)-one (9a) displayed the highest COX-2 selectivity indices of 96, 99, and 98, respectively, and analgesic efficacies of 47%, 46%, and 45% protection, respectively.

View Article and Find Full Text PDF

We report the synthesis and biological evaluation of two new series of 2-amino-6-benzyl-4-phenyl-4,6-dihydrobenzo[c]pyrano[2,3-e][1,2]thiazine-3‑carbonitrile 5,5-dioxides and 2-amino-6-methyl-4-phenyl-4,6-dihydrobenzo[c]pyrano[2,3-e][1,2]thiazine-3‑carbonitrile 5,5-dioxides. The synthetic methodology involves a multistep reaction starting with methyl anthranilate which was coupled with methane sulfonyl chloride. The product of the reaction was subjected to N-benzylation and N-methylation reactions followed by ring closure with sodium hydride resulting in the formation of respective 2,1-benzothiazine 2,2-dioxides.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!